1. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Nolvadex (Tamoxifen Citrate) NDA 017970 approval letter, March 9, 2006. Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017970s054lbl.pdf. Accessed September 4, 2013.
2. Tamoxifen as a potential treatment of glioma;Mastronardi;Anticancer Drugs,1998
3. Clomiphene and anti-oestrogens for ovulation induction in PCOS;Brown;Cochrane Database Syst Rev,2009
4. Tamoxifen-associated eye disease. A review;Nayfield;J Clin Oncol,1996
5. The eyes have it! Tamoxifen maculopathy revisited: a case report;Nair;J Ocul Pharmacol Ther,2012